Nucl Med Mol Imaging.  2017 Mar;51(1):93-96. 10.1007/s13139-016-0437-6.

Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using ¹⁸F-FDG PET/CT

• Park S
• Kim TS
• Kim SK

• KMID: 2373462
• DOI: http://doi.org/10.1007/s13139-016-0437-6

Abstract

¹â¸F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a widely used imaging modality in the initial diagnosis of cancer, treatment response evaluation and detection of recurrence. Herein, we present the case of a 39-year-old female who presented right ptosis on the follow-up of breast cancer after surgery. Clinicians suspected Horner's syndrome, and the patient underwent FDG PET/CT for the evaluation of recurrence that could cause Horner's syndrome. FDG PET/CT demonstrated a focal hypermetabolic lesion in the right cervicothoracic junction area, corresponding to the preganglionic cervical sympathetic trunk. A subsequent needle biopsy was done, and the lesion was confirmed as metastatic ductal carcinoma. In this case, we could detect the exact location of the recurring lesion that caused Horner's syndrome using FDG PET/CT.

Keyword

FDG PET/CT; Horner's syndrome; Breast cancer; Recurrence

MeSH Terms

Adult
Biopsy, Needle
Breast Neoplasms*
Breast*
Carcinoma, Ductal
Diagnosis
Electrons
Female
Follow-Up Studies
Horner Syndrome*
Humans
Positron-Emission Tomography and Computed Tomography*
Recurrence